Author summary: Cytosolic pattern recognition receptors, such as the nucleotide-activated STING 39 molecule, play a critical role in the innate immune system by detecting the presence of intracellular 40 invaders. Brucella bacterial species establish chronic infections in macrophages despite initially 41 activating STING. STING does participate in the control of Brucella infection, as mice or cells lacking 42 STING show a higher burden of Brucella infection. However, we have found that early following 43 infection, Brucella upregulates a microRNA, miR-24, that targets the STING messenger RNA, resulting in 44 lower STING levels. Dead bacteria or bacteria lacking a functional type IV secretion system were 45 defective at upregulating miR-24 and STING suppression, suggesting an active bacteria-driven process. 46
Abstract: Brucellosis, caused by Brucella bacteria species, remains the most prevalent zoonotic disease 17 worldwide. Brucella establish chronic infections within host macrophages despite triggering cytosolic 18 innate immune sensors, including Stimulator of Interferon Genes (STING), which potentially limit 19 infection. In this study, STING was required for control of chronic Brucella infection in vivo. However, 20 early during infection, Brucella down-regulated STING mRNA and protein. Down-regulation occurred 21 post-transcriptionally, required live bacteria, the Brucella type IV secretion system, and was 22 independent of host IRE1-RNase activity. Rather, Brucella induced a STING-targeting microRNA, miR-24-23 2. Furthermore, STING downregulation was inhibited by miR-24 anti-miRs and in mirn23a locus-deficient 24 macrophages. Failure to suppress STING expression in mirn23a -/macrophages correlated with 25 diminished Brucella replication, and was rescued by exogenous miR-24. Anti-miR-24 potently 26 suppressed replication in wild type, but much less in STING -/macrophages, suggesting most of the 27 impact of miR-24 induction on replication occurred via STING suppression. In summary, Brucella Brucella spp. are Gram-negative, facultative intracellular α-proteobacteria which cause the zoonotic 54 disease brucellosis (1, 2) . Human brucellosis is characterized by an acute undulating fever accompanied 55 by flu-like myalgias before developing into a chronic disease, with long-term pathologies such as 56 sacroiliitis, arthritis, liver damage, meningitis, and endocarditis (3). Brucellosis in animals often causes 57 orchitis and sterility in males and spontaneous abortions in females, leading to profound economic loss 58 worldwide (4). During chronic infection, Brucella live and replicate within macrophages and other 59 phagocytes. This intracellular localization renders the organism refractory to even prolonged multiple 60 antibiotic treatments, and relapses occur in 5-10% of cases (3). In the U.S., brucellosis has been largely 61 controlled through vaccination of livestock with live attenuated strains, though outbreaks still occur 62 (Serpa et al. 2018 , Joseph et al. 2018 , Sfeir 2018 . Currently, no safe and effective human vaccine exists. 63
The mechanism(s) involved in supporting the intracellular persistence of Brucella remain unclear. 64
Innate immune responses form the first line of defense against bacterial pathogens. However, Brucella 65 express multiple 'atypical' virulence factors, which stymie innate defenses. For example, Brucella spp. 66 resist complement activation and express a weakly endotoxic "smooth" lipopolysaccharide that is a poor 67 agonist for the innate immune sensor Toll-like receptor 4 (5). Despite sequestration in membranous 68 compartments, Brucella trigger cytosolic innate immune sensors including various inflammasomes and 69 the Stimulator of Interferon Genes (STING) (6-9). STING resides in the endoplasmic reticulum membrane 70 and upon activation by bacterial cyclic-di-nucleotides or cyclic GMP-AMP (c-GAMP), STING translocates 71 to peri-nuclear clusters where it co-localizes with and activates TANK binding kinase I (TBK1), which in 72 turn phosphorylates the IFN-β regulatory transcription factor IRF3 (10, 11). In addition to Type I 73 interferon induction, STING is essential for optimal induction of NF-B-dependent pro-inflammatory 74 cytokines and other host defense genes, and regulates autophagy (12). Evidence from the cancer 75 literature also suggests STING critically supports effective CD8+ T cell adaptive immune responses (13). 76 Previously, we have shown that STING is required for Type I interferon production in response to 77 infection with Brucella abortus, and that STING contributes to control of B. abortus infection at 72 hours 78 in vitro (6, 14) . 79
Here, we report that STING is critical for the control of chronic Brucella infection (3-6 weeks) in vivo. 80 However, early during infection, Brucella down-regulate STING (Tmem173) mRNA expression and 81 protein. Concurrently with STING suppression, Brucella induce a STING-targeting microRNA miR-24. 82 Inhibition by anti-miR-24 or genetic deficiency of miR-24-2 leads to a significant increase in STING 83 expression as well as augmented IFN-β production in macrophages. Inability to induce miR-24 and 84 downregulate STING compromised Brucella survival in macrophages. These results suggest that Brucella 85 mitigates the cost of innate immune activation by targeting STING expression. 86
Results

87
STING is required for chronic control of Brucella in vivo 88
In a previous study, we showed that STING is required for control of Brucella in vitro at 72 hours (14). At 89 an earlier time point (24h), STING (Tmem173) -/macrophages displayed significantly increased Brucella 90 infection ( Figure 1A) . Recently, we have also shown that STING is required for control of Brucella 91 infection in mice at 1 and 3 weeks (15). To confirm these results and evaluate the role of STING in 92 longer-term chronic Brucella infection (16), wild type C57BL/6 and STING -/mice were infected with wild-93 type S2308 Brucella abortus for 3 and 6 weeks. Splenic colony forming units (CFU) showed an 94 approximately two-log difference between STING -/mice and age-matched control C57BL/6 mice at 3 95 weeks and ~1.5 log difference at 6 weeks ( Figure 1B) . These data indicate that STING critically 96 participates in the control of chronic Brucella infection in vivo. 97 98
Brucella infection suppresses STING expression independently of IRE1 endonuclease activity and 99 requires live bacteria and Type IV secretion 100
Given the requirement for STING in the control of chronic infection, it was surprising to note significant 101 STING (Tmem173) mRNA down-regulation in bone marrow-derived macrophages (BMDMs) infected 102 with wild type 16M Brucella melitensis at 24h (published RNAseq data set in Khan et al., 2016) . To 103 via RT-qPCR ( Figure 3D) . Tmem173 levels were unaffected by 4µ8c pre-treatment, indicating that STING 134 mRNA down-regulation does not occur via IRE1-dependent endonuclease activity. 135 136 Brucella infection upregulates miR-24, a STING-targeting microRNA 137
Another hypothesis for the reduction in STING mRNA is that its mRNA is a target of microRNA (miRNA). 138 miRNA are endogenous, small non-coding RNAs 18-25 nucleotides in length that post-transcriptionally 139 regulate gene expression via translational inhibition and mRNA destruction (26). To search for possible 140 miRNAs that target STING, we used the online tool TargetScanMouse to identify possible candidates. A 141 top hit was a conserved micro-RNA miR-24, which has been shown to post-transcriptionally regulate 142 endogenous STING in Rattus norvegicus epithelium cells (27). MiR-24-2 (encoded by the mirn23a locus) 143 was also increased in our RNAseq data set from Brucella-infected macrophages (14). To confirm the 144 effect of infection on miR-24 levels, macrophages were infected for 24 hours with B. melitensis ( Figure  145 4A). Infected macrophages significantly and reliably increased miR-24 levels compared to uninfected 146 cells, although the degree of induction was variable (50% up to 8-fold). To confirm the biologic relevance 147 of this miR-24 increase, we examined expression of another predicted mRNA target BCL2-like 11 (Bim), 148 an apoptosis facilitator (28). Bcl2l11 mRNA levels were also significantly decreased in B. melitensis 149 infected macrophages compared to uninfected cells ( Figure 4B ). Tmem173 levels decreased over time as 150 miR-24 increased (Figure 4C) . Fold induction of miR-24 significantly correlated with the extent of 151
Tmem173 suppression ( Figure 4D) . Just as heat-killed Brucella failed to suppress STING, the killed 152
Brucella did not induce miR-24 expression ( Figure 4E) . Brucella VirB2 mutants also displayed a marked 153 defect in miR-24 induction, consistent with the failure to fully suppress Tmem173 expression ( Figure 4F) . 154
The requirement for live bacteria and the type IV secretion system to induce miR-24 and suppress STING 155 expression suggested an active, bacterially driven process, rather than a passive host response to 156 PAMPs. Intriguingly, Ma et al. had reported that LPS suppressed STING expression via a MyD88-157 dependent pathway (29). The mechanism was, and remains unknown. MyD88, a critical signaling 158 intermediary downstream of multiple Toll-like receptors, is critical for control of Brucella infection in 159 vivo (30, 31) . To determine if MyD88 contributed to Tmem173 downregulation in Brucella-infected 160 macrophages, we compared Tmem173 and miR-24 expression in MyD88 -/and wild type macrophages 161 ( Figure 5A, B) . MyD88 was not required for Tmem173 mRNA suppression or for miR-24 induction, 162 although both were less robust in MyD88 -/cells. Further, miR-24 induction in STING -/macrophages is 163 similar to wild type cells, indicating mir-24 induction does not require STING expression ( Figure 5C) . 164
To confirm that miR-24 is required for the down-regulation of STING and Bim, we utilized anti-miR-24 165 miRNA inhibitors (Supplemental Figure S1 ). The restoration of Tmem173 and Bcl2l11 expression with 166 anti-miR-24 treatment ( Figure 6A) was consistent with the idea that miR-24 contributes to the down-167 regulation of these mRNAs during Brucella infection. STING is required for optimal Brucella-dependent 168 IFN-β production in macrophages (6, 15) . To determine if failure to suppress STING correlated with 169 increased STING activity, we assessed the impact of the anti-miR-24 on IFN- production. As shown in 170 Figure 6B , IFN-β was significantly up-regulated in macrophages transfected with the miR-24 inhibitor 171 compared to mock transfected control cells, consistent with increased STING activity. Together, these 172 data suggest Brucella infection induces miR-24 to down-regulate STING. 173
To further evaluate the requirement for miR-24, we utilized a genetic model of miR-24 deficiency. MiR-174 24-3p is 100% homologous between mouse, rats and human and is expressed from two genetic loci: 175 mirn23a encodes miR-23a, miR-24-2 and miR-27a and mirn23b encodes miR-23b, miR-24-1 and miR-176 27b. Our previous RNAseq data suggested bone marrow macrophages induced miR-24-2 but not miR-177 24-1 (Khan et al. 2016) . Mirn23a is the predominant source of these miR-24 in blood (Kurkewich et al., 178 2018) . Mirn23a -/macrophages showed decreased levels of miR-24 compared to wild type prior to 179 infection and were deficient at miR-24 upregulation in response to Brucella infection ( Figure 6C ). As noted above, heat-killed Brucella did not induce miR-24 in either genotype. Mirn23a -/macrophages 181 were unable to reliably suppress Tmem173 expression at 24h in relation to their uninfected state, 182 although overall levels of Tmem173 mRNA were decreased compared to uninfected wild type 183 macrophages, suggesting a balance between static miR-24 and Tmem173 levels (Figure 6D, E) . The 184 defect in Tmem173 suppression in the mirn23a -/macrophages, more evident over time (Figure 6E) , 185 correlated with greatly increased Ifnb1 induction by 24h post-infection, consistent with increased STING 186 activity ( Figure 6F) . 187
188
Decreased Brucella replication in miR23 locus-/-macrophages. 189
Although the data in Figure 1 suggested that STING regulates Brucella infection, the biologic 190 consequences of miR-24 induction and failure to suppress STING expression were not clear. To 191 determine the role of the mirn23a locus in infection, we compared replication (CFU) in wild type vs. 192 mirn23a -/macrophages ( Figure 7A ). Initial uptake of Brucella was similar between genotypes, but 193 diverged by 8h, with lower Brucella CFU recovered in the mirn23a -/macrophages. This divergence 194 maintained or increased over the course of infection through 48-72 hours. These results were consistent 195 with a role for the miRs encoded by this locus in supporting intracellular infection. To confirm the 196 specificity for miR-24, anti-miR24 and miR-24 mimics (Figure 7B) were introduced. Anti-miR24 greatly 197 decreased the capacity of wild type but not mirn23a -/macrophages to control intracellular B. melitensis 198 replication. In the converse experiment, addition of miR-24 mimics significantly enhanced B. melitensis 199 replication in the mirn23a -/but not always in wild type macrophages. These data were consistent with 200 the hypothesis that miR-24 is responsible for the decreased replication in mirn23a -/cells. Finally, to 201 determine what proportion of the miR-24 effect was due to STING (vs. other miR-24 targets), STING -/-202 macrophages were transfected with anti-miR24 or mimics prior to infection. Whereas anti-miR24 203 suppressed Brucella replication in wild type macrophages, neither mimics nor anti-miRs exerted a 204 significant magnitude of effect on replication in STING -/cells (Figure 7C , anti-miRs: 5-40-fold in wild type 205 vs 24-43% CFU difference in STING -/-). These epistasis results suggested STING accounts for the majority 206 of the miR-24 effect on replication during infection. Together, these data are consistent with the 207 hypothesis that Brucella induction of miR-24 suppresses STING expression to increase infectious success. and STING suppression required live bacteria, and full suppression required the VirB-encoded Type IV 234 secretion system, suggesting an active bacterial driven process rather than a simple host response to 235
Brucella PAMPs. The independence of miR-24 upregulation from STING signaling supports this model. 236
MiR-24 upregulation and STING downregulation were slightly less robust in the MyD88-/-macrophages, 237 consistent with a minor role for MyD88 signaling. The type IV secretion system may contribute to miR-238 24 upregulation through secretion of a specific Brucella substrate or by enabling appropriate 239 intracellular trafficking. The early divergence (4h) of STING expression between mirn23a -/and wild type 240 macrophages suggests that the effect of miR-24 precedes intracellular Brucella replication. 241
Induction of the mirn23a gene locus during infection comes at potential cost for Brucella infection. In NK 242 cells, deletion of this locus (also known as Mirc11) resulted in decreased ability to contain Listeria 243 infection, related to diminished IFN- and pro-inflammatory cytokine production (32). Both IFN- and 244 TNF- have long been known to be critical for control of Brucella infection. However, effects of miR-24 245 on cytokine production may be cell-type specific. In CD4+ T cells, miR-24 was reported to target IFN- 246 mRNA (33). Over-expression of miR-24 in a Staphylococcus aureus infection model decreased "M1" 247 inflammatory mediator production in macrophages and enhanced "M2" marker expression, which 248 would benefit Brucella (34, 35 ). An earlier study had also suggested modulation of macrophage 249 polarization towards an "alternative" M2 phenotype (36) . Manipulation of miR-24 levels had minimal 250 effects on Brucella replication in STING -/cells, suggesting that STING is the dominant or primary target 251 of miR-24 induction during Brucella infection of macrophages that impacts intracellular replication. 252
Recently, the ability of another chronic intracellular pathogen, Mycobacterium tuberculosis, to 253 manipulate host innate responses, autophagy, and apoptosis via host miRNA has garnered much 254 interest (37-40). In contrast, there is much less information regarding miRNA in the context of Brucella Bim and STING, indicating that miR-24 is targeting both these mRNAs during B. melitensis infection. 266
Throughout these experiments, fold-induction of miR-24 strongly correlated with STING mRNA 267 suppression. Our previous RNAseq data set revealed upregulation of miR-24-2, encoded at the mirn23a 268 locus, but not miR-24-1 from the mirn23b locus. Furthermore, although mirn23a -/cells expressed some 269 miR-24, they were unable to upregulate its expression in response to infection. These results suggest that upsetting the balance between miR-24 and Tmem173 levels is the critical component. The strong 271 effects of miR-24 manipulation through mimics and anti-miRs, as well as the defects in replication in the 272 mirn23a -/macrophages together support the idea that upregulation of miR-24 is important for 273 replication early during infection. The greater replication in the mirn23a -/cells vs the anti-miR24 treated 274 wild type macrophages may reflect contributions from miR-23a and miR-27a encoded by that locus 275 (Figure 7) . 276
In addition to the return of STING mRNA, miR-24 inhibition or genetic deficiency resulted in a 277 significantly increased IFN-β response compared to uninhibited macrophages. Although initially 278 identified in its role in viral protection, Type I interferons have recently become a topic of interest in 279 response to many bacterial pathogens (47). During infections, the effect of Type I interferons can be 280 protective or detrimental depending on the bacterial species. For example, Type I interferon protects 281 mice against Salmonella typhimurium infection whereas Interferon-alpha/beta receptor (IFNAR)-282 mediated Type I interferon responses to Francisella tularensis and Listeria monocytogenes is harmful to 283 the host (48-50). The role of Type I interferon in response to Brucella is currently unclear; a study in 284 2007 showed no difference in splenic and liver CFUs in wild type versus IFNAR -/mice (51). However, a 285 more recent study has shown a higher burden of Brucella in wild type mice compared to IFNAR -/mice, 286
indicating that Type I interferon response is detrimental to the host (6). Resistance to B. abortus in the 287 IFNAR -/mice was accompanied by elevated production of IFN-γ and NO, and decreased apoptosis 288 compared to wild-type mice. Although type I IFN served as a useful indicator for STING activity in this 289 study, ultimately, the experience with the IFNAR -/mice suggest STING is controlling infection through 290
Type I IFN-independent mechanisms. 291
Brucella potently inhibits apoptosis, contributing to chronic infection; however, the mechanisms behind 292 this process are unknown (30, 52). By down-regulating STING and subsequent IFN-β production, Brucella 293 could be actively inhibiting apoptosis that is dependent upon Type I IFN signaling. Further, by up-regulating miR-24 which in turn down-regulates Bim, Brucella could be avoiding UPR-mediated 295 apoptosis, which is partially dependent upon Bim in other experimental systems (53). B. melitensis 296 infection robustly induces CHOP, which is an upstream activator of Bim (20, 54). We did not detect a 297 reliable effect of the anti-miR-24 on host cell apoptosis or cell death (data not shown). One likely 298 explanation is that there are unidentified miR-24-independent mechanisms that inhibit apoptosis 299 independently of STING and Bim down-regulation. Indeed, our previous RNAseq data (14) suggested 300 that Brucella suppresses the expression of multiple pro-apoptotic molecules. Another possibility is that 301 the other microRNA at the mirn23a locus counteract the miR-24 Bim mRNA targeting during infection 302 (55). 303
In summary, this is the first report in which an intracellular bacterial pathogen evades full activation of 304 innate immunity by down-regulating STING via miR-24 induction. It is noteworthy that a single miRNA 305 species should have such a profound impact on a major cytosolic innate immune sensor and consequent 306
Brucella replication. Our data may have implications for other important pathogens. For instance, miR-307 24 was up-regulated and cited as one of 7 significantly altered microRNAs controlling the transcriptional 308 response to M. tuberculosis in macrophages (56). In a separate report, in transcriptomic data, Tmem173 309 was suppressed by more than 50% at 4h and >75% decreased 12h following M. tuberculosis infection 310 (57). Widely considered a "stealth" pathogen, Brucella can evade immune surveillance and persist 311 chronically in macrophages (58). In contrast to this idea of Brucella as "flying under the radar", previous 312 reports have described Brucella subversion of toll-like receptor signaling via Btp1/TcpB (59-61). In this 313 study, a single miRNA species exerted a profound effect on a major cytosolic innate immune sensor, 314 with striking impact on intracellular replication. The data presented here present a critical mechanism 315 by which Brucella actively sabotages cytosolic surveillance by the innate immune sensor STING to 316 establish its intracellular niche. 317
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STAR Methods
Mice and Ethics Statement 338
Wild type C57BL/6 mice were purchased from (resource?) and housed at the Federal University of Minas 339 Gerais (UFMG). STING (Tmem173) -/-, mice were described previously (10). All mice were maintained at 340 UFMG and used at six weeks of age. All animal experiments were pre-approved by the Institutional 341 Animal Care and Use Committee of UFMG (CETEA #128/2014). 342
In vivo infections in mice were carried via intraperitoneal injection of 10 6 CFU of B. abortus virulent 343 strain S2308. Five female C57BL/6 and 4-5 STING -/mice were infected with B. abortus and sacrificed at 344 three or six weeks post-infection. To count Brucella CFU, individual spleens were macerated in 10 ml 345 saline, serially diluted, and plated in duplicate on Brucella Broth agar. After 3 days of incubation at 37°C, 346 the number of CFU was determined as described previously (30) . 347
Mammalian Cell Lines 348
V-raf/v-myc immortalized murine bone marrow derived macrophages (BMDM) were a generous gift 349 from Dr. John-Demian Sauer at the University of Wisconsin-Madison. These macrophages were from 350 C57BL/6 mice. V-raf/V-myc immortalized BMDM were generated in our lab from leg bones of MyD88 -/-, 351 STING -/-, and mirn23a -/mice obtained from researchers listed in the table above. These mice all had a 352 C57BL/6 background. All immortalized macrophage cell lines were cultured at 37°C with 5% CO2 in RPMI 353 supplemented with 1mM Na pyruvate, 0.05mM 2-mercaptoethanol, and 10% FBS. Apart from Figure 1 Tsolis). Briefly, exponentially growing Brucella were made electrocompetent following standard 364 microbiological methods. Electrocompetent Brucella were then electroporated with pAV2.2 and VirB2 365 deletion mutants were selected for kanamycin resistance and carbenicillin sensitivity. VirB2 deletion 366 was confirmed in these clones using PCR. 367 In experiments using heat-killed (HK) Brucella as a control, inactivation of Brucella was as follows. After 368 growing Brucella in culture, the sample was quantitated using spectrophotometry. Brucella was then 369 aliquoted in microcentrifuge tubes and placed in a 56C waterbath for 1 h. 370
Immortalized macrophage cell lines were plated on 6-well tissue culture plates at 0.4 x 10 6 cells per well 372 in 2 ml culture media. The next day, the media was replaced, and cells were infected with 100 MOI 373
Brucella determined by spectrophotometry (OD at 600 nm) through a formula established by a Brucella 374 growth curve. Cells were incubated at 37C. Four hours post-infection, cells were washed 3x with 2 375 ml/well warm PBS and fresh media containing 10 g/ml gentamycin was added. Incubation continued 376 until time points indicated for the experimental assays. In some experiments, the IRE1 endonuclease 377 inhibitor 10 µM 4µ8c was added to the cultures 1 hour prior to infection. 378
Colony-Forming Unit (CFU) assays 379
Cells were washed 3x in PBS to remove extracellular bacteria. Then, 1 ml of cell lysis buffer (dH2O + 380 0.1% Triton X-100) was added per well. CFU were determined by serial dilution plating on BHI agar 381 after 3-4 days. 382
Quantitative Polymerase Chain Reaction (qPCR) 383
Total cellular RNA was processed using RNAzol RT reagent (Molecular Research Center, Inc.) following 384 the manufacturer's protocol. Then cDNA was prepared from either mRNA, using the Superscript IV VILO 385 system (Invitrogen) or microRNA using the qScript system (Quanta biosciences). Samples for 386
Quantitative PCR were analyzed using SYBR Green and the delta-delta Ct method to calculate relative 387 fold gene expression using a StepOnePlus thermocycler (ABI). Endogenous genes used for comparative 388 expression were either 18S (mRNA) or RNU6 (microRNA). The primers used in this study were designed 389 using IDT's online primer design tool or purchased. 390
Quantification of IFN-β by ELISA 391
Culture supernatants from cells were collected and frozen at -80C until assayed. A mouse IFN- ELISA 392 kit was used following the manufacturer's protocol. Absorbance at 450 nm and 570 nm were 393 determined utilizing a BioTek microplate reader. Quantitation of mouse IFN- was determined by 394 standard curve. 395
MicroRNA Inhibitor and Mimic Transfection 396
Macrophage cell lines were seeded on 6-well tissue culture plates at 0.4 x 10 6 cells/well. The next day, 397 miRNA mimics (miR-24-3p), miRNA control, and miRNA inhibitors for miR-24-3p were diluted to 0.28 M 398 using Opti-MEM and cells were transfected using using RNAiMAX Reagent following the manufacturer's 399 protocol. One day after transfection, cells were infected as described above. 400
Western Blot Assays 401
Cell lines (infected or control) were washed with PBS and scraped off the well then transferred to a 402 microcentrofuge tube and pelleted (4k RPM, 5 min). Supernatant was completely removed and cells 403 lysed with M-PER reagent (ThermoFisher Scientific) according to the manufacturer's protocol. Whole-404 cell lysates were resolved by 12% SDS-PAGE. Samples were then transferred to polyvinyldene difluoride 405 (PVD) membrane and immunoblotted with anti-STING primary antibody (ThermoFisher Scientific) and 406 anti-β-actin primary antibody (Santa Cruz), followed by a fluorescence-conjugated secondary antibody 407 (LI-COR). Proteins were visualized and quantitated with the Odyssey system (LI-COR). 408
Quantification and Statistical Analysis 409
CFU values were and standardized mRNA expression levels were summarized in terms of means ± 410 standard deviations and displayed in graphical format using bar charts, stratified by experimental 411 conditions. Comparisons between experimental groups were conducted using two-sample t-test or 412 analysis of variance (ANOVA). Pairwise comparisons between multiple groups were conducted using 413
Tukey's Honestly Significance Difference (HSD) method. Residual and normal probability plots were 414 examined to verify the model assumptions. Linear regression and Pearson's correlation analyses were 415 conducted to evaluate bivariate associations. Statistical significance is indicated in the figures (* p<0.05, 416 ** p<0.01, *** p<0.005, **** p<0.001, ns not significant). Statistical analyses were conducted using SAS 417 (SAS Institute Inc., Cary NC), version 9.4. 418 
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